Baird Financial Group
DPLO

Baird Financial Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Baird Financial Group’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-6,372
Closed -$223K – 1238
2016
Q2 		$223K Buy
+6,372
New +$200K ﹤0.01% 1119
2015
Q4 		– Sell
-17,420
Closed -$500K – 1303
2015
Q3 		$500K Sell
17,420
-6,813
-28% -$291K 0.01% 907
2015
Q2 		$1.08M Buy
+24,233
New +$912K 0.01% 731

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Baird Financial Group's DPLO Position: Q3 2016 in Review

Baird Financial Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2016, closing a stake of 6,372 shares — an estimated $223K sold.

Baird Financial Group first reported a position in DPLO in Q2 2015 and held it in 3 quarters. The position peaked at $1.08M in Q2 2015. 185 funds tracked by Wall St. Rank hold DPLO as of Q3 2016.

  • Baird Financial Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2016 after selling out during the quarter.
  • Baird Financial Group sold 6,372 DIPLOMAT PHARMACY, INC. shares in Q3 2016, an estimated $223K.
  • Baird Financial Group first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 3 quarters.
  • Baird Financial Group's DIPLOMAT PHARMACY, INC. position peaked at $1.08M in Q2 2015.
  • 185 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2016.

Based on Baird Financial Group's 13F filing for Q3 2016, filed 10 Nov 2016.